Compare BridgeBio Pharma Inc (BBIO) vs Gogoro Inc (GGR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Gogoro Inc — how do they compare? BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B), while Gogoro Inc trades at $2.67 (market cap $52.19M). The key difference: BridgeBio Pharma Inc is far larger — about 313.5× Gogoro Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Gogoro Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | GGR | |
|---|---|---|
Market Cap | $16.36B | $52.19M |
Sector | Health | Technology |
52-Week High | $90.17 | $7.50 |
52-Week Low | $47.29 | $2.55 |
Enterprise Value | $18.14B | $354.63M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Gogoro Inc
Gogoro is a global technology leader in battery-swapping ecosystems for electric two-wheelers. It provides smart, sustainable urban mobility solutions and manages an extensive network of battery stations.
Read more on GGR →
